<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Prevention and control</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Prevention and control</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Prevention and control</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anthony Harris, MD, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel J Sexton, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Keri K Hall, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 28, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Prevention and control of methicillin-resistant <em>Staphylococcus aureus</em> (MRSA) infection is among the most important challenges of infection prevention. Factors in transmission include colonization, impaired host defenses, and contact with skin or contaminated fomites [<a href="#rid1">1-3</a>]. Worldwide, an estimated 15 percent of infections are caused by <em>S. aureus</em>, nearly one-third of those (31 percent) are due to MRSA [<a href="#rid4">4</a>].</p><p>The success of MRSA control has varied substantially with different strategies [<a href="#rid5">5,6</a>]. Numerous guidelines have been published from countries around the world:</p><p class="bulletIndent1"><span class="glyph">●</span>In 2023, United States guidelines were updated, entitled "SHEA/IDSA/APIC Practice recommendation: Strategies to prevent methicillin-resistant <em>Staphylococcus aureus </em>transmission and infection in acute care hospitals: 2022 update [<a href="#rid5">5</a>]."</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Guidelines for Europe and specific European countries can be found online: <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.ecdc.europa.eu%2Fen%2Fpublications-data%2Fdirectory-guidance-prevention-and-control%2Fprevention-and-control-infections-0&amp;token=%2BP4x%2FynmC1zJNg%2FZfdeesDvZDSHVGom727MsOF8FublPr7xwj0qyoLodRewQ%2BWEPpgSfy3G1hML0KEcS26qsMvucKlwk%2B9IEkGkNXUqXNraiuTW%2B%2FRWKmFH30Bol1zt0&amp;TOPIC_ID=4048" target="_blank">European MRSA prevention guidelines</a> [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other guidelines have also been published [<a href="#rid7">7</a>].</p><p></p><p>Issues related to epidemiology of MRSA are discussed further separately. (See  <a class="medical medical_review" href="/d/html/3157.html" rel="external">"Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Epidemiology"</a>.)</p><p>Issues related to prevention and control of MRSA outside intensive care units will be reviewed here. Issues related to prevention of MRSA infection in intensive care units are discussed separately. (See  <a class="medical medical_review" href="/d/html/3810.html" rel="external">"Nosocomial infections in the intensive care unit: Epidemiology and prevention"</a>.)</p><p class="headingAnchor" id="H11536922"><span class="h1">IN HEALTH CARE SETTINGS</span></p><p class="headingAnchor" id="H11536733"><span class="h2">Basic infection prevention principles</span><span class="headingEndMark"> — </span>Principles of infection prevention for reducing spread of MRSA include attention to careful hand hygiene and adherence to contact precautions for care of patients with known MRSA infection.</p><p class="headingAnchor" id="H2909027781"><span class="h3">Hand hygiene</span><span class="headingEndMark"> — </span>Hand hygiene consists of cleaning hands with soap and water or an alcohol-based hand gel before and after clinical encounters with patients who have MRSA infection [<a href="#rid8">8</a>]. Hand hygiene is an important factor in controlling the transmission of health care-associated infection [<a href="#rid9">9</a>]. This was illustrated in a study in which implementation of a hand-hygiene campaign led to an increase in the rate of hand hygiene compliance (48 to 66 percent) with a concomitant decrease in the rate of MRSA transmission (2.16 to 0.93 episodes per 10,000 patient-days) and the overall rate of health care-associated infections (16.9 to 9.9 percent) [<a href="#rid9">9</a>]. Thus to help control MRSA, health care workers and institutions should aim to follow the Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) hand hygiene guidance recommendations [<a href="#rid10">10,11</a>].</p><p>General principles regarding hand hygiene are discussed further separately. (See  <a class="medical medical_review" href="/d/html/4042.html" rel="external">"Infection prevention: Precautions for preventing transmission of infection", section on 'Hand hygiene'</a>.)</p><p class="headingAnchor" id="H2048869456"><span class="h3">Contact precautions</span><span class="headingEndMark"> — </span>Contact precautions include use of gowns and gloves during clinical encounters with patients who have MRSA infection; multiple studies have demonstrated the efficacy of contact precautions for reducing spread of MRSA [<a href="#rid12">12-14</a>]. Patients colonized or infected with MRSA may be cohorted with other such patients. MRSA colonization status should be noted in the hospital record so that appropriate precautions can be arranged promptly if colonized patients require repeat admission [<a href="#rid15">15</a>].</p><p>General principles regarding contact precautions are discussed further separately. (See  <a class="medical medical_review" href="/d/html/4042.html" rel="external">"Infection prevention: Precautions for preventing transmission of infection", section on 'Contact precautions'</a>.)</p><p>The optimal approach for discontinuation of contact precautions for MRSA is uncertain [<a href="#rid5">5</a>]. Guidelines regarding the duration of contact precautions for acute care settings were published in 2018 by the Society for Healthcare Epidemiology of America (SHEA) [<a href="#rid16">16</a>]. For patients who have been previously colonized or infected with MRSA who are not on antibiotics with activity against MRSA, these guidelines suggest discontinuation of contact precautions after documentation of one to three negative weekly surveillance cultures; most patients remain negative for MRSA colonization after three consecutive weekly surveillance cultures [<a href="#rid17">17</a>]. The optimal sampling site is uncertain; the anterior nares are a commonly used site. For patients who may be at higher risk for persistent MRSA colonization and recolonization (such as those with chronic wounds or patients from long-term care facilities), the guidelines indicate extension of contact precautions is reasonable. The optimal duration of extension is unknown; a minimum of six months is commonly used.</p><p>This guidance is in agreement with the United States Centers for Disease Control and Prevention, which has indicated that, in general, it is reasonable to discontinue contact precautions when three or more surveillance cultures are negative over the course of a week or two in the absence of antimicrobial therapy (for several weeks), a draining wound, respiratory secretions, [<a href="#rid18">18</a>].</p><p>One randomized trial comparing active screening with passive screening among more than 600 patients with prior documented MRSA colonization noted that active screening led to more frequent discontinuation of contact precautions when they were no longer needed (relative risk 2.5; 95% CI 1.5-4.7), resulting in reduction in inappropriate isolation and cost of isolation [<a href="#rid19">19</a>].</p><p>The major downside of contact precautions is increased cost [<a href="#rid20">20,21</a>]. Some studies favor elimination of contact precautions for patients with MRSA [<a href="#rid22">22-24</a>]; however, these studies are underpowered and lack controls for confounding variables such as universal gloving. A recent quasi-experimental study across all 123 VA hospitals showed some of the hazards of discontinuing contact precautions or active surveillance hospitals and the subsequent increase in MRSA infection rates among facilities discontinuing active surveillance and contact precautions [<a href="#rid25">25</a>]. Some centers have discontinued the use of contact precautions in certain situations. Guidelines suggest that sites considering moving away from contact precautions for patients with MRSA should: (a) perform a risk assessment; (b) reinstitute contact precautions with increases in MRSA rates; (c) consider using contact precautions in high-risk settings such as ICU patients, burn units, dialysis patients, transplant patients, and residents of long-term care facilities. These recommendations constitute a more customized "middle ground approach," but do not endorse abandoning all MRSA contact precautions [<a href="#rid26">26</a>]. Hospitals not using contact precautions should also have optimal programs in other areas of infection control including hand hygiene, environmental cleaning, and targeted decolonization protocols.</p><p>Principles regarding contact precautions are discussed further separately. (See  <a class="medical medical_review" href="/d/html/4042.html" rel="external">"Infection prevention: Precautions for preventing transmission of infection", section on 'Contact precautions'</a>.)</p><p class="headingAnchor" id="H2"><span class="h2">Role of active surveillance</span></p><p class="headingAnchor" id="H11535969"><span class="h3">Definitions</span><span class="headingEndMark"> — </span>Active surveillance consists of performing screening cultures (of the nares, oropharynx, and/or perineum) to identify asymptomatic patients who are colonized with antibiotic-resistant bacteria, with the goal of intervening to minimize the likelihood of spread to other patients (via implementation of contact precautions) [<a href="#rid12">12</a>]. A proportion of patients with MRSA colonization develop MRSA infection, and transmission occurs from both colonized and infected patients [<a href="#rid15">15,27-29</a>]. The rate of progression from colonization to infection has been estimated to be between 9 to 33 percent [<a href="#rid5">5,29-34</a>].</p><p>The anterior nares are a frequent site of MRSA carriage (positive in 73 to 93 percent of carriers); however, nasal colonization has not been universally found among MRSA-positive patients with implanted devices, and the rectum may be an important reservoir among those with community-acquired MRSA [<a href="#rid35">35-37</a>]. Areas of skin breakdown may be colonized with MRSA, and sampling such areas is a reasonable option if other sites are not cultured or are culture-negative.</p><p>Different microbiologic methods exist for surveillance testing; these include standard microbiology methods, selective media, and polymerase chain reaction-based tests. Rapid whole-genome sequencing is an alternative method that may be useful for outbreak investigation but is not yet widely available for routine clinical use [<a href="#rid38">38,39</a>]. (See  <a class="medical medical_review" href="/d/html/3166.html" rel="external">"Rapid detection of methicillin-resistant Staphylococcus aureus"</a>.)</p><p>Clinical cultures alone may underestimate the prevalence of MRSA by as much as 85 percent [<a href="#rid37">37,40</a>]. Health care settings not using active surveillance are able to identify patients with MRSA infection only via clinical cultures obtained from symptomatic patients (ie, passive surveillance). </p><p class="headingAnchor" id="H3"><span class="h3">Clinical approach</span><span class="headingEndMark"> — </span>The optimal role for active surveillance is not known, and there is insufficient evidence for a single routine approach [<a href="#rid5">5</a>]. Active surveillance cultures appear to be most useful in the setting of hospital outbreaks and among patients at high risk for MRSA carriage [<a href="#rid41">41</a>]. MRSA risk factors include [<a href="#rid41">41-54</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>History of MRSA colonization (such patients should be isolated initially pending surveillance testing results)</p><p class="bulletIndent1"><span class="glyph">●</span>Intensive care unit (ICU) admission</p><p class="bulletIndent1"><span class="glyph">●</span>Severe underlying illness or comorbid conditions</p><p class="bulletIndent1"><span class="glyph">●</span>Prolonged hospital stay </p><p class="bulletIndent1"><span class="glyph">●</span>Indwelling device such as central venous catheter</p><p class="bulletIndent1"><span class="glyph">●</span>Residence in long-term care facility or exposure to correctional facilities, crowding, or unstable housing</p><p class="bulletIndent1"><span class="glyph">●</span>Patients on hemodialysis</p><p class="bulletIndent1"><span class="glyph">●</span>Patients hospitalized in the previous 12 months</p><p class="bulletIndent1"><span class="glyph">●</span>Broad-spectrum antibiotic exposure in the last three months</p><p class="bulletIndent1"><span class="glyph">●</span>Injection drug use</p><p></p><p>Advocates of active surveillance have pointed to its success in several European countries where MRSA has been contained at a low prevalence (examples include the Netherlands, Finland, and France) [<a href="#rid55">55-59</a>]. These strategies involved a multifaceted approach including surveillance, contact isolation, health care worker screening with decolonization, and closing units for comprehensive screening and cleaning when warranted [<a href="#rid60">60-62</a>]. Given this combination of interventions, it is not certain which intervention or combination of interventions is required for MRSA control. Therefore, extrapolating these experiences to other health care settings with variable MRSA prevalence and other factors is difficult and sometimes impossible.</p><p>In the United States, the Veterans Affairs has mandated active surveillance along with other infection control interventions including contact precautions that have led to a decrease in MRSA [<a href="#rid63">63</a>]. Other states have also mandated active surveillance for MRSA [<a href="#rid64">64</a>]. The 2023 United States guidelines consider active surveillance as "additional but not essential intervention" [<a href="#rid5">5</a>]. The latest US guidelines also state that hospitals choosing not to do whole-hospital active surveillance should consider instituting a more targeted policy based on high-risk patients or high-risk encounters and should use their MRSA-targeted risk assessment to decide whether they should use active surveillance.</p><p>Institutions performing surveillance cultures should establish clear policies regarding how the results will be used to make decisions about contact precautions, cohorting, and decolonization. Educational programming about adherence for patients, visitors, health care workers, environmental cleaners, and other hospital personnel is recommended.</p><p class="headingAnchor" id="H672071589"><span class="h2">Decolonization</span></p><p class="headingAnchor" id="H8"><span class="h3">Routine chlorhexidine bathing</span><span class="headingEndMark"> — </span>Routine inpatient <a class="drug drug_general" data-topicid="9244" href="/d/drug information/9244.html" rel="external">chlorhexidine</a> bathing has been shown to be useful for reducing MRSA colonization and infection; these issues are discussed separately: </p><p class="bulletIndent1"><span class="glyph">●</span>Issues related to patient bathing in intensive care units are discussed separately. (See  <a class="medical medical_review" href="/d/html/3810.html" rel="external">"Nosocomial infections in the intensive care unit: Epidemiology and prevention", section on 'Patient bathing/decolonization'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Issues related to patient bathing in non-critical care units are discussed separately. (See  <a class="medical medical_review" href="/d/html/4042.html" rel="external">"Infection prevention: Precautions for preventing transmission of infection", section on 'Patient bathing'</a>.)</p><p></p><p class="headingAnchor" id="H9"><span class="h3">Targeted decolonization</span><span class="headingEndMark"> — </span>Issues related to efficacy and clinical approach to targeted decolonization are discussed in the following sections. Issues related to MRSA epidemiology are discussed further separately. (See  <a class="medical medical_review" href="/d/html/3157.html" rel="external">"Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Epidemiology", section on 'MRSA colonization'</a>.)</p><p>MRSA nasal colonization appears to precede infection, although asymptomatic nasal carriage is not always identifiable in the setting of MRSA infections [<a href="#rid65">65</a>]. In addition, the durability of MRSA decolonization is limited [<a href="#rid12">12</a>]. </p><p class="headingAnchor" id="H3915799119"><span class="h3">Patients with medical devices</span><span class="headingEndMark"> — </span>Some expert guidelines recommend targeted decolonization of known MRSA carriers who have medical devices, such as central lines, mid-line catheters, and lumbar drains. This recommendation is based mainly on the ABATE trial, a cluster-randomized trial of 53 hospitals comparing routine bathing to decolonization with universal <a class="drug drug_general" data-topicid="9244" href="/d/drug information/9244.html" rel="external">chlorhexidine</a> and targeted nasal <a class="drug drug_general" data-topicid="9668" href="/d/drug information/9668.html" rel="external">mupirocin</a> in noncritical care units [<a href="#rid66">66</a>]. MRSA and VRE clinical culture positivity was unchanged in the study-population, but a subset of patients with medical devices appeared to benefit from decolonization.</p><p class="headingAnchor" id="H3994733887"><span class="h4">At time of hospital discharge</span><span class="headingEndMark"> — </span>For hospitalized patients with MRSA infection or MRSA colonization, we favor initiating a decolonization regimen at the time of hospital discharge to reduce the likelihood of subsequent MRSA infection. </p><p>The optimal regimen and duration of decolonization are uncertain. The best-studied regimen consists of 4% rinse-off <a class="drug drug_general" data-topicid="9244" href="/d/drug information/9244.html" rel="external">chlorhexidine</a> for daily bathing or showering, 0.12% chlorhexidine mouthwash twice daily, and 2% nasal <a class="drug drug_general" data-topicid="9668" href="/d/drug information/9668.html" rel="external">mupirocin</a> twice daily, all administered for five days twice per month for six months [<a href="#rid30">30</a>]. However, adherence to this regimen outside the context of a clinical trial has been difficult; it is uncertain whether less intensive regimens would have comparable efficacy. </p><p>The above approach is supported by a randomized trial including more than 2000 hospitalized patients with MRSA colonization managed with education with or without decolonization (<a class="drug drug_general" data-topicid="9244" href="/d/drug information/9244.html" rel="external">chlorhexidine</a> for daily bathing or showering, chlorhexidine mouthwash, and nasal <a class="drug drug_general" data-topicid="9668" href="/d/drug information/9668.html" rel="external">mupirocin</a> for five days twice per month for six months) at the time of discharge [<a href="#rid30">30</a>]. Use of postdischarge decolonization was associated with a 30 percent reduction (from 9.2 to 6.3 percent) in the rate of MRSA infection during the year after discharge (hazard ratio 0.70, 95% CI 0.52-0.96); the number needed to treat to prevent one MRSA infection was 30. About two-thirds of participants in the decolonization group were able to adhere fully to the regimen; among these individuals, there were 44 percent fewer MRSA infections and 40 percent fewer infections from any cause.</p><p>In other studies, briefer decolonization regimens (such as a single five-day course) have been associated with short-lived success for prevention of infection during temporary high-risk circumstances [<a href="#rid67">67-69</a>]. </p><p><a class="drug drug_general" data-topicid="9668" href="/d/drug information/9668.html" rel="external">Mupirocin</a> and <a class="drug drug_general" data-topicid="9244" href="/d/drug information/9244.html" rel="external">chlorhexidine</a> resistance may occur [<a href="#rid70">70</a>]. Mupirocin resistance occurred in 24 percent of MRSA isolates in one study [<a href="#rid71">71-75</a>]. The gene for high-level mupirocin resistance, <em>mupA</em>, has been found on a plasmid in USA300 MRSA clones, suggesting that the future utility of this drug may be limited since this clone has been implicated in many community-associated MRSA infections [<a href="#rid76">76,77</a>]. Thus far, no breakpoints have been established for mupirocin susceptibility testing, and commercial tests are limited [<a href="#rid78">78</a>].</p><p class="headingAnchor" id="H4103502244"><span class="h4">Prior to surgery</span><span class="headingEndMark"> — </span>Issues related to MRSA decolonization in patients undergoing surgery are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/4044.html" rel="external">"Overview of control measures for prevention of surgical site infection in adults", section on 'S. aureus decolonization'</a>.)</p><p class="headingAnchor" id="H19"><span class="h2">Environmental cleaning</span><span class="headingEndMark"> — </span>MRSA-colonized and MRSA-infected patients readily contaminate the inanimate environment in their hospital room or home. Health care providers who come into contact with a colonized patient or their surrounding inanimate environment can in turn easily contaminate their hands, clothing, and medical equipment [<a href="#rid14">14,79-82</a>]. Meticulous cleaning of patient care surfaces is essential for control of MRSA environmental contamination [<a href="#rid5">5,12,83,84</a>]. MRSA can survive on surfaces for hours, days, or months but is killed by to routinely used hospital disinfectants. The viability of MRSA on inanimate surfaces and object depends on a variety of factors including temperature, humidity, the number of organisms present, and the type of surface.</p><p>Medical equipment should be dedicated to a single patient when possible to avoid transfer of pathogens via fomites. Equipment that must be shared should be cleaned and disinfected before use for another patient [<a href="#rid12">12</a>].</p><p>Environmental services personnel should be included as an integral part of the infection prevention team. Checklists for cleaning frequently touched patient care surfaces (such as bed controls, light switches, doorknobs, etc) can be useful for reinforcing consistency [<a href="#rid41">41</a>]. Ultraviolet markers may be useful for monitoring thoroughness of room cleaning [<a href="#rid85">85-87</a>].</p><p>Issues related to environmental cleaning are discussed further separately. (See  <a class="medical medical_review" href="/d/html/101613.html" rel="external">"Infection prevention: General principles"</a>.)</p><p class="headingAnchor" id="H20"><span class="h2">Antibiotic stewardship</span><span class="headingEndMark"> — </span>Inappropriate or excessive antibiotic use can lead to selection of resistant organisms [<a href="#rid88">88,89</a>]. The risk of MRSA colonization has been correlated with the frequency and duration of prior antimicrobial therapy [<a href="#rid90">90,91</a>]. Several studies have documented a higher risk of MRSA colonization following therapy with fluoroquinolones and other antibiotics that do not have MRSA coverage [<a href="#rid92">92-95</a>]. Reductions in the use of certain antibiotics within hospital systems can reduce the incidence of MRSA infection [<a href="#rid96">96-98</a>]. However, altering an antibiotic formulary can in turn lead to emergence of other resistant pathogens [<a href="#rid88">88,97</a>]. Two out of three systematic reviews and/or meta-analyses found an association between implementation of antimicrobial stewardship interventions and a decreased incidence of MRSA infection and/or colonization [<a href="#rid99">99-101</a>]. These data led the SHEA/IDSA/APIC MRSA compendium to change antibiotic stewardship from an additional practice to an essential practice in the latest 2023 guidelines. </p><p class="headingAnchor" id="H21"><span class="h1">IN THE COMMUNITY</span><span class="headingEndMark"> — </span>Risk factors for MRSA infection are summarized in the table  (<a class="graphic graphic_table graphicRef53504" href="/d/graphic/53504.html" rel="external">table 1</a>). Tools for preventing MRSA spread in the community include hand hygiene, minimizing transmission risk, decolonization and reducing broad-spectrum antibiotic use [<a href="#rid54">54</a>]. </p><p class="headingAnchor" id="H1473798825"><span class="h2">Minimizing transmission risk</span></p><p class="headingAnchor" id="H3028900725"><span class="h3">Hand hygiene</span><span class="headingEndMark"> — </span>Hand hygiene is as important in the community as in the hospital. Hands should be cleaned thoroughly with soap and water or an alcohol-based hand sanitizer, immediately after touching the skin or any item that has come in direct contact with a draining wound. (See <a class="local">'Hand hygiene'</a> above.)</p><p class="headingAnchor" id="H309069840"><span class="h3">Other measures</span><span class="headingEndMark"> — </span>Wounds that are draining should be kept covered with clean, dry bandages. Patients with open wounds should not participate in activities involving skin-to-skin contact with others until wounds are fully healed. Individuals should avoid sharing personal items that may become contaminated with wound drainage, such as towels, clothing, bedding, bar soap, razors, or athletic equipment that touches the skin. Clothing that comes into contact with wound drainage should be laundered and dried thoroughly. Environmental surfaces with which multiple individuals have bare skin contact should be cleaned with an over-the-counter cleaner with activity against <em>S. aureus</em>. Cross-transmission of MRSA between humans and their pets has been described [<a href="#rid2">2,102-104</a>].</p><p class="headingAnchor" id="H1692346621"><span class="h2">Decolonization</span></p><p class="headingAnchor" id="H1591123693"><span class="h3">Clinical approach</span><span class="headingEndMark"> — </span>In the outpatient setting, decolonization is reasonable for patients with recurrent MRSA infection despite hygiene optimization and/or if ongoing transmission is occurring among household members or other close contacts [<a href="#rid8">8,105</a>].</p><p>The optimal approach to decolonization is uncertain; we favor one of the following regimens (administered to the patient as well as household members) [<a href="#rid8">8,105</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>Nasal decolonization with <a class="drug drug_general" data-topicid="9668" href="/d/drug information/9668.html" rel="external">mupirocin</a> ointment (2%) applied to nares twice daily for 5 to 10 days, and</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Topical body decolonization (one of the following):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9244" href="/d/drug information/9244.html" rel="external">Chlorhexidine</a> gluconate (2% or 4% solution): daily washes or use of a disposable impregnated cloth for 5 to 14 days, or</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Dilute bleach baths (one teaspoon bleach per gallon of water, or one-fourth cup bleach per one-fourth tub [approximately 13 gallons of water] for 15 minutes twice weekly) for approximately three months</p><p></p><p>Following decolonization, surveillance cultures are not necessary in the absence of active infection [<a href="#rid8">8</a>].</p><p>The efficacy of decolonization in outpatient settings is limited. Based on available data, the above approach may temporarily eradicate MRSA colonization, but there is no definitive evidence that it reduces the likelihood of subsequent infection [<a href="#rid71">71,106-114</a>]. Given the observed reduction in MRSA infection rate associated with a longer (six-month) decolonization regimen at the time of hospital discharge [<a href="#rid30">30</a>], further study of longer decolonization regimens among patients in community settings is warranted. (See <a class="local">'At time of hospital discharge'</a> above.)</p><p>In one randomized trial including 300 adults and children with community-onset skin and soft tissue infection (SSTI) and <em>S. aureus</em> colonization randomized to no therapeutic intervention (control group) or one of three five-day decolonization regimens (regimen 1: 2% <a class="drug drug_general" data-topicid="9668" href="/d/drug information/9668.html" rel="external">mupirocin</a> ointment applied to the nares twice daily, regimen 2: intranasal mupirocin plus daily 4% <a class="drug drug_general" data-topicid="9244" href="/d/drug information/9244.html" rel="external">chlorhexidine</a> body washes, or regimen 3: intranasal mupirocin plus daily dilute bleach water baths), eradication rates were 48, 56, 54, and 71 percent, respectively [<a href="#rid107">107</a>]. In a retrospective study including more than 900 patients with MRSA colonization who underwent decolonization and follow-up for subsequent MRSA infection (five-day course of nasal mupirocin ointment [2%] plus chlorhexidine gluconate [4%] every second day), decolonization did not affect the risk of infection but there was a trend toward delayed infection in patients following decolonization (median time to infection 50.0 versus 15.5 days; p = .06) [<a href="#rid114">114</a>].</p><p>Decolonization of the patient and household (rather than the decolonization of the patient only) is supported by a randomized trial including more than 180 patients with MRSA SSTI randomized to decolonization of all household members (household group) or decolonization of the patient alone (index group); during the 12-month followup, recurrent SSTI was observed less frequently in the household group than the index group (52 versus 72 percent) [<a href="#rid115">115</a>]. </p><p>Emergence of <em>S. aureus</em> strains tolerant or resistant to topical antimicrobial agents used for decolonization is well described; however, the clinical impact of reduced susceptibility is not clear [<a href="#rid78">78</a>].</p><p class="headingAnchor" id="H3424899808"><span class="h3">Recurrent infection despite decolonization</span><span class="headingEndMark"> — </span>Following a failed initial decolonization attempt, the likelihood of successful decolonization is relatively low. If repeat infection occurs, repeat decolonization may be attempted with the topical agents as outlined above [<a href="#rid8">8</a>]. In addition, some clinicians favor concomitant administration of oral antibiotic therapy; this decision should be made based on individual circumstances. The optimal regimen and duration of oral antibiotic therapy are uncertain; data are limited. Options include <a class="drug drug_general" data-topicid="9864" href="/d/drug information/9864.html" rel="external">rifampin</a> (600 mg orally once daily) administered in combination with either <a class="drug drug_general" data-topicid="9393" href="/d/drug information/9393.html" rel="external">doxycycline</a> (100 mg orally twice daily) or <a class="drug drug_general" data-topicid="9785" href="/d/drug information/9785.html" rel="external">trimethoprim-sulfamethoxazole</a> (one double-strength tab orally twice daily) for a 5- to 10-day course. </p><p>In one prospective study including 31 patients with recurrent MRSA SSTI who underwent decolonization with nasal and topical body decolonization as well as oral antibiotic therapy; during the six-month followup period, the mean number of MRSA infections per month was reduced from baseline (0.84 to 0.03 infections/month) [<a href="#rid116">116</a>].</p><p class="headingAnchor" id="H78185130"><span class="h2">Reducing broad-spectrum antibiotic use</span><span class="headingEndMark"> — </span>Referral of patients who are labeled as penicillin-allergic for skin testing and evaluation may help mitigate the risk of developing MRSA infections by reducing overall exposure to broad-spectrum antibiotics [<a href="#rid117">117</a>]. In a large cohort study of ambulatory adults, those labeled as penicillin-allergic were more likely to receive broad-spectrum antibiotics, including fluoroquinolones, and were at significantly higher risk for the development of MRSA than those without this label [<a href="#rid118">118</a>]. Approximately 95 percent of patients with a history of penicillin allergy will be found to tolerate penicillins following an allergy evaluation [<a href="#rid119">119,120</a>]. (See  <a class="medical medical_review" href="/d/html/111361.html" rel="external">"Choice of antibiotics in penicillin-allergic hospitalized patients", section on 'Impact of penicillin allergy on care'</a>.)</p><p class="headingAnchor" id="H4071442649"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/110550.html" rel="external">"Society guideline links: Management of <i>Staphylococcus aureus</i> infection"</a> and  <a class="medical medical_society_guidelines" href="/d/html/115160.html" rel="external">"Society guideline links: Infection control"</a>.)</p><p class="headingAnchor" id="H22"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topic (see  <a class="medical medical_patient" href="/d/html/4025.html" rel="external">"Patient education: Methicillin-resistant Staphylococcus aureus (MRSA) (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H23"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Basic principles</strong> – Basic infection prevention principles include attention to careful hand hygiene, environmental cleaning, prudent antibiotic use, and, in some centers, adherence to contact precautions for care of patients with known methicillin-resistant <em>Staphylococcus aureus </em>(MRSA) infection. (See <a class="local">'Basic infection prevention principles'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Active surveillance</strong> – Active surveillance cultures identify asymptomatic individuals with MRSA colonization to be placed on contact precautions with the goal of minimizing MRSA spread to other patients. This practice is appropriate in the setting of an outbreak; its role for routine screening is a question of ongoing debate. (See <a class="local">'Role of active surveillance'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Decolonization programs</strong> – For hospitalized patients with MRSA infection or MRSA colonization, we suggest initiating a decolonization regimen at the time of hospital discharge (<a class="grade" href="https://medilib.ir/uptodate/show/grade_5" rel="external">Grade 2B</a>). If possible, we favor the best studied regimen which consists of 4% rinse-off <a class="drug drug_general" data-topicid="9244" href="/d/drug information/9244.html" rel="external">chlorhexidine</a> for daily bathing or showering, 0.12% chlorhexidine mouthwash twice daily, and 2% nasal <a class="drug drug_general" data-topicid="9668" href="/d/drug information/9668.html" rel="external">mupirocin</a> twice daily, all administered for five days twice per month for six months. However, adherence to this regimen outside the context of a clinical trial may be difficult; it is uncertain whether less intensive regimens would have comparable efficacy. (See <a class="local">'Targeted decolonization'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preventing community spread</strong> – Tools for preventing MRSA spread in the community include minimizing transmission risk, decolonization, and reducing broad-spectrum antibiotic use. (See <a class="local">'In the community'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Outpatient decolonization</strong> – In the outpatient setting, we suggest decolonization for patients with recurrent MRSA infection despite hygiene optimization and/or if ongoing transmission is occurring among household members or other close contacts (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Decolonization'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Miller LG, Diep BA. Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2008; 46:752.</a></li><li><a class="nounderline abstract_t">Miller LG, Eells SJ, David MZ, et al. Staphylococcus aureus skin infection recurrences among household members: an examination of host, behavioral, and pathogen-level predictors. Clin Infect Dis 2015; 60:753.</a></li><li><a class="nounderline abstract_t">Lee AS, de Lencastre H, Garau J, et al. Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Primers 2018; 4:18033.</a></li><li><a class="nounderline abstract_t">Vincent JL, Sakr Y, Singer M, et al. Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017. JAMA 2020; 323:1478.</a></li><li><a class="nounderline abstract_t">Popovich KJ, Aureden K, Ham DC, et al. SHEA/IDSA/APIC Practice Recommendation: Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol 2023; :1.</a></li><li class="breakAll">Meticillin-resistant Staphylococcus aureus (MRSA). European Centre for Disease Prevention and Control. Available at: https://www.ecdc.europa.eu/en/publications-data/directory-guidance-prevention-and-control/prevention-and-control-infections-0 (Accessed on July 03, 2023).</li><li><a class="nounderline abstract_t">Coia JE, Wilson JA, Bak A, et al. Joint Healthcare Infection Society (HIS) and Infection Prevention Society (IPS) guidelines for the prevention and control of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 2021; 118S:S1.</a></li><li><a class="nounderline abstract_t">Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52:e18.</a></li><li><a class="nounderline abstract_t">Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet 2000; 356:1307.</a></li><li class="breakAll">Infection prevention and control. Hand hygiene. World Health Organization. Available at: https://www.who.int/teams/integrated-health-services/infection-prevention-control/hand-hygiene (Accessed on June 30, 2023).</li><li class="breakAll">Hand Hygiene in Healthcare Settings. Hand Hygiene Guidance. Centers for Disease Control and Prevention. Available at: https://www.cdc.gov/handhygiene/providers/guideline.html (Accessed on June 30, 2023).</li><li><a class="nounderline abstract_t">Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 2003; 24:362.</a></li><li><a class="nounderline abstract_t">Harbarth S, Masuet-Aumatell C, Schrenzel J, et al. Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study. Crit Care 2006; 10:R25.</a></li><li><a class="nounderline abstract_t">O'Hara LM, Calfee DP, Miller LG, et al. Optimizing Contact Precautions to Curb the Spread of Antibiotic-resistant Bacteria in Hospitals: A Multicenter Cohort Study to Identify Patient Characteristics and Healthcare Personnel Interactions Associated With Transmission of Methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2019; 69:S171.</a></li><li><a class="nounderline abstract_t">Calfee DP, Salgado CD, Milstone AM, et al. Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014; 35 Suppl 2:S108.</a></li><li><a class="nounderline abstract_t">Banach DB, Bearman G, Barnden M, et al. Duration of Contact Precautions for Acute-Care Settings. Infect Control Hosp Epidemiol 2018; 39:127.</a></li><li><a class="nounderline abstract_t">Huckabee CM, Huskins WC, Murray PR. Predicting clearance of colonization with vancomycin-resistant Enterococci and methicillin-resistant Staphylococcus aureus by use of weekly surveillance cultures. J Clin Microbiol 2009; 47:1229.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Multidrug-resistant organisms (MDRO) Management. http://www.cdc.gov/infectioncontrol/guidelines/MDRO/index.html (Accessed on February 12, 2021).</li><li><a class="nounderline abstract_t">Shenoy ES, Kim J, Rosenberg ES, et al. Discontinuation of contact precautions for methicillin-resistant staphylococcus aureus: a randomized controlled trial comparing passive and active screening with culture and polymerase chain reaction. Clin Infect Dis 2013; 57:176.</a></li><li><a class="nounderline abstract_t">Harris AD, Pineles L, Belton B, et al. Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial. JAMA 2013; 310:1571.</a></li><li><a class="nounderline abstract_t">Croft LD, Harris AD, Pineles L, et al. The Effect of Universal Glove and Gown Use on Adverse Events in Intensive Care Unit Patients. Clin Infect Dis 2015; 61:545.</a></li><li><a class="nounderline abstract_t">Edmond MB, Masroor N, Stevens MP, et al. The Impact of Discontinuing Contact Precautions for VRE and MRSA on Device-Associated Infections. Infect Control Hosp Epidemiol 2015; 36:978.</a></li><li><a class="nounderline abstract_t">Martin EM, Russell D, Rubin Z, et al. Elimination of Routine Contact Precautions for Endemic Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: A Retrospective Quasi-Experimental Study. Infect Control Hosp Epidemiol 2016; 37:1323.</a></li><li><a class="nounderline abstract_t">Marra AR, Edmond MB, Schweizer ML, et al. Discontinuing contact precautions for multidrug-resistant organisms: A systematic literature review and meta-analysis. Am J Infect Control 2018; 46:333.</a></li><li><a class="nounderline abstract_t">Evans ME, Simbartl LA, McCauley BP, et al. Active Surveillance and Contact Precautions for Preventing Methicillin-Resistant Staphylococcus aureus Healthcare-Associated Infections During the COVID-19 Pandemic. Clin Infect Dis 2023; 77:1381.</a></li><li><a class="nounderline abstract_t">Bearman GM, Harris AD, Tacconelli E. Contact precautions for the control of endemic pathogens: Finding the middle path. Antimicrob Steward Healthc Epidemiol 2023; 3:e57.</a></li><li><a class="nounderline abstract_t">Harris AD, Furuno JP, Roghmann MC, et al. Targeted surveillance of methicillin-resistant Staphylococcus aureus and its potential use to guide empiric antibiotic therapy. Antimicrob Agents Chemother 2010; 54:3143.</a></li><li><a class="nounderline abstract_t">Nelson RE, Stevens VW, Jones M, et al. Health care-associated methicillin-resistant Staphylococcus aureus infections increases the risk of postdischarge mortality. Am J Infect Control 2015; 43:38.</a></li><li><a class="nounderline abstract_t">Datta R, Huang SS. Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers. Clin Infect Dis 2008; 47:176.</a></li><li><a class="nounderline abstract_t">Huang SS, Singh R, McKinnell JA, et al. Decolonization to Reduce Postdischarge Infection Risk among MRSA Carriers. N Engl J Med 2019; 380:638.</a></li><li><a class="nounderline abstract_t">Huang SS, Hinrichsen VL, Datta R, et al. Methicillin-resistant Staphylococcus aureus infection and hospitalization in high-risk patients in the year following detection. PLoS One 2011; 6:e24340.</a></li><li><a class="nounderline abstract_t">Garrouste-Orgeas M, Timsit JF, Kallel H, et al. Colonization with methicillin-resistant Staphylococcus aureus in ICU patients: morbidity, mortality, and glycopeptide use. Infect Control Hosp Epidemiol 2001; 22:687.</a></li><li><a class="nounderline abstract_t">Freitas EA, Harris RM, Blake RK, Salgado CD. Prevalence of USA300 strain type of methicillin-resistant Staphylococcus aureus among patients with nasal colonization identified with active surveillance. Infect Control Hosp Epidemiol 2010; 31:469.</a></li><li><a class="nounderline abstract_t">Milstone AM, Goldner BW, Ross T, et al. Methicillin-resistant Staphylococcus aureus colonization and risk of subsequent infection in critically ill children: importance of preventing nosocomial methicillin-resistant Staphylococcus aureus transmission. Clin Infect Dis 2011; 53:853.</a></li><li><a class="nounderline abstract_t">Sanford MD, Widmer AF, Bale MJ, et al. Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1994; 19:1123.</a></li><li><a class="nounderline abstract_t">Eveillard M, de Lassence A, Lancien E, et al. Evaluation of a strategy of screening multiple anatomical sites for methicillin-resistant Staphylococcus aureus at admission to a teaching hospital. Infect Control Hosp Epidemiol 2006; 27:181.</a></li><li><a class="nounderline abstract_t">Huang SS, Rifas-Shiman SL, Warren DK, et al. Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units. J Infect Dis 2007; 195:330.</a></li><li><a class="nounderline abstract_t">Köser CU, Holden MT, Ellington MJ, et al. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N Engl J Med 2012; 366:2267.</a></li><li><a class="nounderline abstract_t">Gordon NC, Pichon B, Golubchik T, et al. Whole-Genome Sequencing Reveals the Contribution of Long-Term Carriers in Staphylococcus aureus Outbreak Investigation. J Clin Microbiol 2017; 55:2188.</a></li><li><a class="nounderline abstract_t">Salgado CD, Farr BM. What proportion of hospital patients colonized with methicillin-resistant Staphylococcus aureus are identified by clinical microbiological cultures? Infect Control Hosp Epidemiol 2006; 27:116.</a></li><li><a class="nounderline abstract_t">Peterson LR, Hacek DM, Robicsek A. 5 Million Lives Campaign. Case study: an MRSA intervention at Evanston Northwestern Healthcare. Jt Comm J Qual Patient Saf 2007; 33:732.</a></li><li><a class="nounderline abstract_t">Huskins WC, Huckabee CM, O'Grady NP, et al. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med 2011; 364:1407.</a></li><li><a class="nounderline abstract_t">Harbarth S, Fankhauser C, Schrenzel J, et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008; 299:1149.</a></li><li><a class="nounderline abstract_t">Glick SB, Samson DJ, Huang ES, et al. Screening for methicillin-resistant Staphylococcus aureus: a comparative effectiveness review. Am J Infect Control 2014; 42:148.</a></li><li><a class="nounderline abstract_t">Huang SS, Septimus E, Kleinman K, et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 2013; 368:2255.</a></li><li><a class="nounderline abstract_t">Shitrit P, Gottesman BS, Katzir M, et al. Active surveillance for methicillin-resistant Staphylococcus aureus (MRSA) decreases the incidence of MRSA bacteremia. Infect Control Hosp Epidemiol 2006; 27:1004.</a></li><li><a class="nounderline abstract_t">Jernigan JA, Titus MG, Gröschel DH, et al. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol 1996; 143:496.</a></li><li><a class="nounderline abstract_t">Wernitz MH, Swidsinski S, Weist K, et al. Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to prevent hospital-acquired MRSA infections. Clin Microbiol Infect 2005; 11:457.</a></li><li><a class="nounderline abstract_t">Huang SS, Yokoe DS, Hinrichsen VL, et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2006; 43:971.</a></li><li><a class="nounderline abstract_t">Khoury J, Jones M, Grim A, et al. Eradication of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit by active surveillance and aggressive infection control measures. Infect Control Hosp Epidemiol 2005; 26:616.</a></li><li><a class="nounderline abstract_t">Jain R, Kralovic SM, Evans ME, et al. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med 2011; 364:1419.</a></li><li><a class="nounderline abstract_t">Lucet JC, Chevret S, Durand-Zaleski I, et al. Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit: results of a multicenter study. Arch Intern Med 2003; 163:181.</a></li><li><a class="nounderline abstract_t">Furuno JP, McGregor JC, Harris AD, et al. Identifying groups at high risk for carriage of antibiotic-resistant bacteria. Arch Intern Med 2006; 166:580.</a></li><li><a class="nounderline abstract_t">Hidron AI, Kourbatova EV, Halvosa JS, et al. Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage. Clin Infect Dis 2005; 41:159.</a></li><li><a class="nounderline abstract_t">Vriens M, Blok H, Fluit A, et al. Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch University Medical Center: a 10-year survey. Eur J Clin Microbiol Infect Dis 2002; 21:782.</a></li><li><a class="nounderline abstract_t">Kotilainen P, Routamaa M, Peltonen R, et al. Elimination of epidemic methicillin-resistant Staphylococcus aureus from a university hospital and district institutions, Finland. Emerg Infect Dis 2003; 9:169.</a></li><li><a class="nounderline abstract_t">Harbarth S, Pittet D. Control of nosocomial methicillin-resistant Staphylococcus aureus: where shall we send our hospital director next time? Infect Control Hosp Epidemiol 2003; 24:314.</a></li><li><a class="nounderline abstract_t">van Trijp MJ, Melles DC, Hendriks WD, et al. Successful control of widespread methicillin-resistant Staphylococcus aureus colonization and infection in a large teaching hospital in the Netherlands. Infect Control Hosp Epidemiol 2007; 28:970.</a></li><li><a class="nounderline abstract_t">Wertheim HF, Ammerlaan HS, Bonten MJ, et al. [Optimisation of the antibiotic policy in the Netherlands. XII. The SWAB guideline for antimicrobial eradication of MRSA in carriers]. Ned Tijdschr Geneeskd 2008; 152:2667.</a></li><li><a class="nounderline abstract_t">Pan A, Carnevale G, Catenazzi P, et al. Trends in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: effect of the MRSA "search and isolate" strategy in a hospital in Italy with hyperendemic MRSA. Infect Control Hosp Epidemiol 2005; 26:127.</a></li><li><a class="nounderline abstract_t">Verhoef J, Beaujean D, Blok H, et al. A Dutch approach to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1999; 18:461.</a></li><li><a class="nounderline abstract_t">Kluytmans-Vandenbergh MF, Kluytmans JA, Voss A. Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO). Infection 2005; 33:309.</a></li><li><a class="nounderline abstract_t">Evans ME, Kralovic SM, Simbartl LA, et al. Eight years of decreased methicillin-resistant Staphylococcus aureus health care-associated infections associated with a Veterans Affairs prevention initiative. Am J Infect Control 2017; 45:13.</a></li><li><a class="nounderline abstract_t">Lin MY, Hayden MK, Lyles RD, et al. Regional Epidemiology of Methicillin-Resistant Staphylococcus aureus Among Adult Intensive Care Unit Patients Following State-Mandated Active Surveillance. Clin Infect Dis 2018; 66:1535.</a></li><li><a class="nounderline abstract_t">Mody L, Kauffman CA, Donabedian S, et al. Epidemiology of Staphylococcus aureus colonization in nursing home residents. Clin Infect Dis 2008; 46:1368.</a></li><li><a class="nounderline abstract_t">Huang SS, Septimus E, Kleinman K, et al. Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial. Lancet 2019; 393:1205.</a></li><li><a class="nounderline abstract_t">Septimus EJ, Schweizer ML. Decolonization in Prevention of Health Care-Associated Infections. Clin Microbiol Rev 2016; 29:201.</a></li><li><a class="nounderline abstract_t">Wertheim HF, Verveer J, Boelens HA, et al. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults. Antimicrob Agents Chemother 2005; 49:1465.</a></li><li><a class="nounderline abstract_t">Immerman I, Ramos NL, Katz GM, et al. The persistence of Staphylococcus aureus decolonization after mupirocin and topical chlorhexidine: implications for patients requiring multiple or delayed procedures. J Arthroplasty 2012; 27:870.</a></li><li><a class="nounderline abstract_t">Lee AS, Macedo-Vinas M, François P, et al. Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study. Clin Infect Dis 2011; 52:1422.</a></li><li><a class="nounderline abstract_t">Simor AE, Phillips E, McGeer A, et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 2007; 44:178.</a></li><li><a class="nounderline abstract_t">Jones JC, Rogers TJ, Brookmeyer P, et al. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clin Infect Dis 2007; 45:541.</a></li><li><a class="nounderline abstract_t">Simor AE, Stuart TL, Louie L, et al. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals. Antimicrob Agents Chemother 2007; 51:3880.</a></li><li><a class="nounderline abstract_t">Miller MA, Dascal A, Portnoy J, Mendelson J. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 1996; 17:811.</a></li><li><a class="nounderline abstract_t">Teo BW, Low SJ, Ding Y, et al. High prevalence of mupirocin-resistant staphylococci in a dialysis unit where mupirocin and chlorhexidine are routinely used for prevention of catheter-related infections. J Med Microbiol 2011; 60:865.</a></li><li><a class="nounderline abstract_t">Diep BA, Gill SR, Chang RF, et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 2006; 367:731.</a></li><li><a class="nounderline abstract_t">Driscoll DG, Young CL, Ochsner UA. Transient loss of high-level mupirocin resistance in Staphylococcus aureus due to MupA polymorphism. Antimicrob Agents Chemother 2007; 51:2247.</a></li><li><a class="nounderline abstract_t">Madden GR, Sifri CD. Antimicrobial Resistance to Agents Used for Staphylococcus aureus Decolonization: Is There a Reason for Concern? Curr Infect Dis Rep 2018; 20:26.</a></li><li><a class="nounderline abstract_t">Bhalla A, Pultz NJ, Gries DM, et al. Acquisition of nosocomial pathogens on hands after contact with environmental surfaces near hospitalized patients. Infect Control Hosp Epidemiol 2004; 25:164.</a></li><li><a class="nounderline abstract_t">Sexton T, Clarke P, O'Neill E, et al. Environmental reservoirs of methicillin-resistant Staphylococcus aureus in isolation rooms: correlation with patient isolates and implications for hospital hygiene. J Hosp Infect 2006; 62:187.</a></li><li><a class="nounderline abstract_t">Weber DJ, Anderson D, Rutala WA. The role of the surface environment in healthcare-associated infections. Curr Opin Infect Dis 2013; 26:338.</a></li><li><a class="nounderline abstract_t">Nadimpalli G, O'Hara LM, Pineles L, et al. Patient to healthcare personnel transmission of MRSA in the non-intensive care unit setting. Infect Control Hosp Epidemiol 2020; 41:601.</a></li><li><a class="nounderline abstract_t">Rutala WA, Stiegel MM, Sarubbi FA, Weber DJ. Susceptibility of antibiotic-susceptible and antibiotic-resistant hospital bacteria to disinfectants. Infect Control Hosp Epidemiol 1997; 18:417.</a></li><li><a class="nounderline abstract_t">Dancer SJ. Importance of the environment in meticillin-resistant Staphylococcus aureus acquisition: the case for hospital cleaning. Lancet Infect Dis 2008; 8:101.</a></li><li><a class="nounderline abstract_t">Carling PC, Parry MF, Bruno-Murtha LA, Dick B. Improving environmental hygiene in 27 intensive care units to decrease multidrug-resistant bacterial transmission. Crit Care Med 2010; 38:1054.</a></li><li><a class="nounderline abstract_t">Rutala WA, Gergen MF, Weber DJ. Room decontamination with UV radiation. Infect Control Hosp Epidemiol 2010; 31:1025.</a></li><li><a class="nounderline abstract_t">Datta R, Platt R, Yokoe DS, Huang SS. Environmental cleaning intervention and risk of acquiring multidrug-resistant organisms from prior room occupants. Arch Intern Med 2011; 171:491.</a></li><li><a class="nounderline abstract_t">Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007; 44:159.</a></li><li><a class="nounderline abstract_t">Society for Healthcare Epidemiology of America, Infectious Diseases Society of America, Pediatric Infectious Diseases Society. Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect Control Hosp Epidemiol 2012; 33:322.</a></li><li><a class="nounderline abstract_t">Monnet DL. Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: possible implications for control. Infect Control Hosp Epidemiol 1998; 19:552.</a></li><li><a class="nounderline abstract_t">Dancer SJ. The effect of antibiotics on methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2008; 61:246.</a></li><li><a class="nounderline abstract_t">Dziekan G, Hahn A, Thüne K, et al. Methicillin-resistant Staphylococcus aureus in a teaching hospital: investigation of nosocomial transmission using a matched case-control study. J Hosp Infect 2000; 46:263.</a></li><li><a class="nounderline abstract_t">Hori S, Sunley R, Tami A, Grundmann H. The Nottingham Staphylococcus aureus population study: prevalence of MRSA among the elderly in a university hospital. J Hosp Infect 2002; 50:25.</a></li><li><a class="nounderline abstract_t">Campillo B, Dupeyron C, Richardet JP. Epidemiology of hospital-acquired infections in cirrhotic patients: effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis. Epidemiol Infect 2001; 127:443.</a></li><li><a class="nounderline abstract_t">Kanwar A, Cadnum JL, Jencson AL, Donskey CJ. Impact of Antibiotic Treatment on the Burden of Nasal Staphylococcus aureus among Hospitalized Patients. Antimicrob Agents Chemother 2018; 62.</a></li><li><a class="nounderline abstract_t">Fukatsu K, Saito H, Matsuda T, et al. Influences of type and duration of antimicrobial prophylaxis on an outbreak of methicillin-resistant Staphylococcus aureus and on the incidence of wound infection. Arch Surg 1997; 132:1320.</a></li><li><a class="nounderline abstract_t">Landman D, Chockalingam M, Quale JM. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin Infect Dis 1999; 28:1062.</a></li><li><a class="nounderline abstract_t">Tacconelli E, De Angelis G, Cataldo MA, et al. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother 2008; 61:26.</a></li><li><a class="nounderline abstract_t">Karanika S, Paudel S, Grigoras C, et al. Systematic Review and Meta-analysis of Clinical and Economic Outcomes from the Implementation of Hospital-Based Antimicrobial Stewardship Programs. Antimicrob Agents Chemother 2016; 60:4840.</a></li><li><a class="nounderline abstract_t">Baur D, Gladstone BP, Burkert F, et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis 2017; 17:990.</a></li><li><a class="nounderline abstract_t">Davey P, Marwick CA, Scott CL, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2017; 2:CD003543.</a></li><li><a class="nounderline abstract_t">Strommenger B, Kehrenberg C, Kettlitz C, et al. Molecular characterization of methicillin-resistant Staphylococcus aureus strains from pet animals and their relationship to human isolates. J Antimicrob Chemother 2006; 57:461.</a></li><li><a class="nounderline abstract_t">Boost MV, O'Donoghue MM, Siu KH. Characterisation of methicillin-resistant Staphylococcus aureus isolates from dogs and their owners. Clin Microbiol Infect 2007; 13:731.</a></li><li><a class="nounderline abstract_t">Davis MF, Misic AM, Morris DO, et al. Genome sequencing reveals strain dynamics of methicillin-resistant Staphylococcus aureus in the same household in the context of clinical disease in a person and a dog. Vet Microbiol 2015; 180:304.</a></li><li><a class="nounderline abstract_t">Creech CB, Al-Zubeidi DN, Fritz SA. Prevention of Recurrent Staphylococcal Skin Infections. Infect Dis Clin North Am 2015; 29:429.</a></li><li><a class="nounderline abstract_t">Ellis MW, Schlett CD, Millar EV, et al. Hygiene strategies to prevent methicillin-resistant Staphylococcus aureus skin and soft tissue infections: a cluster-randomized controlled trial among high-risk military trainees. Clin Infect Dis 2014; 58:1540.</a></li><li><a class="nounderline abstract_t">Fritz SA, Camins BC, Eisenstein KA, et al. Effectiveness of measures to eradicate Staphylococcus aureus carriage in patients with community-associated skin and soft-tissue infections: a randomized trial. Infect Control Hosp Epidemiol 2011; 32:872.</a></li><li><a class="nounderline abstract_t">Kaplan SL, Forbes A, Hammerman WA, et al. Randomized trial of "bleach baths" plus routine hygienic measures vs. routine hygienic measures alone for prevention of recurrent infections. Clin Infect Dis 2014; 58:679.</a></li><li><a class="nounderline abstract_t">Buehlmann M, Frei R, Fenner L, et al. Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriers. Infect Control Hosp Epidemiol 2008; 29:510.</a></li><li><a class="nounderline abstract_t">Sandri AM, Dalarosa MG, Ruschel de Alcantara L, et al. Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA. Infect Control Hosp Epidemiol 2006; 27:185.</a></li><li><a class="nounderline abstract_t">Watanakunakorn C, Brandt J, Durkin P, et al. The efficacy of mupirocin ointment and chlorhexidine body scrubs in the eradication of nasal carriage of Staphylococcus aureus among patients undergoing long-term hemodialysis. Am J Infect Control 1992; 20:138.</a></li><li><a class="nounderline abstract_t">Wendt C, Schinke S, Württemberger M, et al. Value of whole-body washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: a randomized, placebo-controlled, double-blind clinical trial. Infect Control Hosp Epidemiol 2007; 28:1036.</a></li><li><a class="nounderline abstract_t">Ammerlaan HS, Kluytmans JA, Wertheim HF, et al. Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. Clin Infect Dis 2009; 48:922.</a></li><li><a class="nounderline abstract_t">Robicsek A, Beaumont JL, Thomson RB Jr, et al. Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk. Infect Control Hosp Epidemiol 2009; 30:623.</a></li><li><a class="nounderline abstract_t">Fritz SA, Hogan PG, Hayek G, et al. Household versus individual approaches to eradication of community-associated Staphylococcus aureus in children: a randomized trial. Clin Infect Dis 2012; 54:743.</a></li><li><a class="nounderline abstract_t">Miller LG, Tan J, Eells SJ, et al. Prospective investigation of nasal mupirocin, hexachlorophene body wash, and systemic antibiotics for prevention of recurrent community-associated methicillin-resistant Staphylococcus aureus infections. Antimicrob Agents Chemother 2012; 56:1084.</a></li><li><a class="nounderline abstract_t">Matte G, Shuster J, Guevremont C, et al. Standardization and Updating of a Drug Allergy Testing Program: The McGill Experience and Impact on Pharmacy Activities. Can J Hosp Pharm 2020; 73:45.</a></li><li><a class="nounderline abstract_t">Blumenthal KG, Lu N, Zhang Y, et al. Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study. BMJ 2018; 361:k2400.</a></li><li><a class="nounderline abstract_t">Sacco KA, Bates A, Brigham TJ, et al. Clinical outcomes following inpatient penicillin allergy testing: A systematic review and meta-analysis. Allergy 2017; 72:1288.</a></li><li><a class="nounderline abstract_t">Khan DA, Banerji A, Blumenthal KG, et al. Drug allergy: A 2022 practice parameter update. J Allergy Clin Immunol 2022; 150:1333.</a></li></ol></div><div id="topicVersionRevision">Topic 4048 Version 47.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18220477" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25428411" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Staphylococcus aureus skin infection recurrences among household members: an examination of host, behavioral, and pathogen-level predictors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29849094" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Methicillin-resistant Staphylococcus aureus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32207816" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37381690" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : SHEA/IDSA/APIC Practice Recommendation: Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute-care hospitals: 2022 Update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37381690" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : SHEA/IDSA/APIC Practice Recommendation: Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute-care hospitals: 2022 Update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34757174" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Joint Healthcare Infection Society (HIS) and Infection Prevention Society (IPS) guidelines for the prevention and control of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21208910" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11073019" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11073019" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11073019" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12785411" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16469125" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31517979" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Optimizing Contact Precautions to Curb the Spread of Antibiotic-resistant Bacteria in Hospitals: A Multicenter Cohort Study to Identify Patient Characteristics and Healthcare Personnel Interactions Associated With Transmission of Methicillin-resistant Staphylococcus aureus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25376072" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute care hospitals: 2014 update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29321078" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Duration of Contact Precautions for Acute-Care Settings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19244462" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Predicting clearance of colonization with vancomycin-resistant Enterococci and methicillin-resistant Staphylococcus aureus by use of weekly surveillance cultures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19244462" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Predicting clearance of colonization with vancomycin-resistant Enterococci and methicillin-resistant Staphylococcus aureus by use of weekly surveillance cultures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23572482" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Discontinuation of contact precautions for methicillin-resistant staphylococcus aureus: a randomized controlled trial comparing passive and active screening with culture and polymerase chain reaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24097234" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25900169" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The Effect of Universal Glove and Gown Use on Adverse Events in Intensive Care Unit Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25915205" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The Impact of Discontinuing Contact Precautions for VRE and MRSA on Device-Associated Infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27457254" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Elimination of Routine Contact Precautions for Endemic Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: A Retrospective Quasi-Experimental Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29031432" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Discontinuing contact precautions for multidrug-resistant organisms: A systematic literature review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37390613" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Active Surveillance and Contact Precautions for Preventing Methicillin-Resistant Staphylococcus aureus Healthcare-Associated Infections During the COVID-19 Pandemic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37008747" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Contact precautions for the control of endemic pathogens: Finding the middle path.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20479207" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Targeted surveillance of methicillin-resistant Staphylococcus aureus and its potential use to guide empiric antibiotic therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25564122" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Health care-associated methicillin-resistant Staphylococcus aureus infections increases the risk of postdischarge mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18532892" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30763195" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Decolonization to Reduce Postdischarge Infection Risk among MRSA Carriers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21949707" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Methicillin-resistant Staphylococcus aureus infection and hospitalization in high-risk patients in the year following detection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11842988" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Colonization with methicillin-resistant Staphylococcus aureus in ICU patients: morbidity, mortality, and glycopeptide use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20225966" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Prevalence of USA300 strain type of methicillin-resistant Staphylococcus aureus among patients with nasal colonization identified with active surveillance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21878424" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Methicillin-resistant Staphylococcus aureus colonization and risk of subsequent infection in critically ill children: importance of preventing nosocomial methicillin-resistant Staphylococcus aureus transmission.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7888543" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16465635" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Evaluation of a strategy of screening multiple anatomical sites for methicillin-resistant Staphylococcus aureus at admission to a teaching hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17205470" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22693998" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28468851" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Whole-Genome Sequencing Reveals the Contribution of Long-Term Carriers in Staphylococcus aureus Outbreak Investigation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16465626" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : What proportion of hospital patients colonized with methicillin-resistant Staphylococcus aureus are identified by clinical microbiological cultures?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18200898" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : 5 Million Lives Campaign. Case study: an MRSA intervention at Evanston Northwestern Healthcare.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21488763" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Intervention to reduce transmission of resistant bacteria in intensive care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18334690" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24360519" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Screening for methicillin-resistant Staphylococcus aureus: a comparative effectiveness review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23718152" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Targeted versus universal decolonization to prevent ICU infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17006805" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Active surveillance for methicillin-resistant Staphylococcus aureus (MRSA) decreases the incidence of MRSA bacteremia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8610665" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15882195" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to prevent hospital-acquired MRSA infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16983607" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16092741" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Eradication of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit by active surveillance and aggressive infection control measures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21488764" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12546608" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit: results of a multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16534047" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Identifying groups at high risk for carriage of antibiotic-resistant bacteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15983910" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12461587" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch University Medical Center: a 10-year survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12603986" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Elimination of epidemic methicillin-resistant Staphylococcus aureus from a university hospital and district institutions, Finland.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12785402" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Control of nosocomial methicillin-resistant Staphylococcus aureus: where shall we send our hospital director next time?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17620246" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Successful control of widespread methicillin-resistant Staphylococcus aureus colonization and infection in a large teaching hospital in the Netherlands.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19137966" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : [Optimisation of the antibiotic policy in the Netherlands. XII. The SWAB guideline for antimicrobial eradication of MRSA in carriers].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15756881" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Trends in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: effect of the MRSA "search and isolate" strategy in a hospital in Italy with hyperendemic MRSA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10482021" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : A Dutch approach to methicillin-resistant Staphylococcus aureus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16258859" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28065327" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Eight years of decreased methicillin-resistant Staphylococcus aureus health care-associated infections associated with a Veterans Affairs prevention initiative.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29228133" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Regional Epidemiology of Methicillin-Resistant Staphylococcus aureus Among Adult Intensive Care Unit Patients Following State-Mandated Active Surveillance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18419438" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Epidemiology of Staphylococcus aureus colonization in nursing home residents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30850112" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26817630" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Decolonization in Prevention of Health Care-Associated Infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15793127" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22397861" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : The persistence of Staphylococcus aureus decolonization after mupirocin and topical chlorhexidine: implications for patients requiring multiple or delayed procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21628482" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17173213" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17682986" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17724154" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8985769" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21317195" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : High prevalence of mupirocin-resistant staphylococci in a dialysis unit where mupirocin and chlorhexidine are routinely used for prevention of catheter-related infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16517273" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17438053" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Transient loss of high-level mupirocin resistance in Staphylococcus aureus due to MupA polymorphism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29882094" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Antimicrobial Resistance to Agents Used for Staphylococcus aureus Decolonization: Is There a Reason for Concern?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14994944" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Acquisition of nosocomial pathogens on hands after contact with environmental surfaces near hospitalized patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16290319" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Environmental reservoirs of methicillin-resistant Staphylococcus aureus in isolation rooms: correlation with patient isolates and implications for hospital hygiene.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23743816" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : The role of the surface environment in healthcare-associated infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32036800" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Patient to healthcare personnel transmission of MRSA in the non-intensive care unit setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9181398" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Susceptibility of antibiotic-susceptible and antibiotic-resistant hospital bacteria to disinfectants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17974481" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Importance of the environment in meticillin-resistant Staphylococcus aureus acquisition: the case for hospital cleaning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20081531" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Improving environmental hygiene in 27 intensive care units to decrease multidrug-resistant bacterial transmission.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20804377" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Room decontamination with UV radiation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21444840" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Environmental cleaning intervention and risk of acquiring multidrug-resistant organisms from prior room occupants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17173212" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22418625" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9758054" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: possible implications for control.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18057071" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : The effect of antibiotics on methicillin-resistant Staphylococcus aureus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11170757" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Methicillin-resistant Staphylococcus aureus in a teaching hospital: investigation of nosocomial transmission using a matched case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11825048" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : The Nottingham Staphylococcus aureus population study: prevalence of MRSA among the elderly in a university hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11811877" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Epidemiology of hospital-acquired infections in cirrhotic patients: effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30012763" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Impact of Antibiotic Treatment on the Burden of Nasal Staphylococcus aureus among Hospitalized Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9403537" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Influences of type and duration of antimicrobial prophylaxis on an outbreak of methicillin-resistant Staphylococcus aureus and on the incidence of wound infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10452635" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17986491" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27246783" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Systematic Review and Meta-analysis of Clinical and Economic Outcomes from the Implementation of Hospital-Based Antimicrobial Stewardship Programs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28629876" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28178770" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Interventions to improve antibiotic prescribing practices for hospital inpatients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16387748" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Molecular characterization of methicillin-resistant Staphylococcus aureus strains from pet animals and their relationship to human isolates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17484762" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Characterisation of methicillin-resistant Staphylococcus aureus isolates from dogs and their owners.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26411322" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Genome sequencing reveals strain dynamics of methicillin-resistant Staphylococcus aureus in the same household in the context of clinical disease in a person and a dog.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26311356" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Prevention of Recurrent Staphylococcal Skin Infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24633684" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Hygiene strategies to prevent methicillin-resistant Staphylococcus aureus skin and soft tissue infections: a cluster-randomized controlled trial among high-risk military trainees.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21828967" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Effectiveness of measures to eradicate Staphylococcus aureus carriage in patients with community-associated skin and soft-tissue infections: a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24265356" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Randomized trial of "bleach baths" plus routine hygienic measures vs. routine hygienic measures alone for prevention of recurrent infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18510460" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16465636" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1636934" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : The efficacy of mupirocin ointment and chlorhexidine body scrubs in the eradication of nasal carriage of Staphylococcus aureus among patients undergoing long-term hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17932823" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Value of whole-body washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: a randomized, placebo-controlled, double-blind clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19231978" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19496730" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22198793" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Household versus individual approaches to eradication of community-associated Staphylococcus aureus in children: a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22083485" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Prospective investigation of nasal mupirocin, hexachlorophene body wash, and systemic antibiotics for prevention of recurrent community-associated methicillin-resistant Staphylococcus aureus infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32109960" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Standardization and Updating of a Drug Allergy Testing Program: The McGill Experience and Impact on Pharmacy Activities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29950489" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28370003" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Clinical outcomes following inpatient penicillin allergy testing: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36122788" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Drug allergy: A 2022 practice parameter update.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
